Disase Detail : MGeND

Information

Disease name: proctitis
Disease ID: DOID:3127
Description: "A rectal disease that involves inflammation of the rectal mucosa, which results from infection, inflammatory bowel disease, or radiation. Sexually transmitted pathogens (Neisseria gonorrhoeae, Chlamydia trachomatis, herpes simplex virus 1 and 2, Treponema pallidum) and enteric pathogens (Campylobacter, Shigella, Salmonella) are involved in the disease. Symptoms are rectal discomfort and bleeding." [url:http\://www.cdc.gov/std/Treatment/2006/proctitis.htm, url:http\://www.merck.com/mmpe/sec02/ch020/ch020i.html#sec02-ch020-ch020g-1361]

Disease area statistics

[No Data.]

Chromosome band

[No Data.]

Annotation

Genes	Mutation	Description	Source	Links

NCT ID	Status	Phase	Summary	Start date	Completion date
NCT01008410	Completed	Phase 3	Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis	November 17, 2009	April 29, 2013
NCT01008423	Completed	Phase 3	Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis	November 20, 2009	March 18, 2013
NCT01837615	Completed	Phase 2	Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis	January 2013	June 2015
NCT01966783	Completed	Phase 2	Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis	September 2013	August 2015
NCT01172444	Terminated	Phase 3	Clinical Trial With Mesalamine 1g Suppositories	June 2010	December 2012
NCT01349673	Terminated	Phase 3	The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis	May 31, 2011	December 31, 2014

proctitis